Clinical Report: Decline of Infectious Disease Specialists Threatens U.S. Healthcare
Overview
The infectious disease (ID) specialty in the U.S. is shrinking despite rising infectious threats, with nearly 50% of ID training programs unfilled and only about 14,000 ID physicians nationwide. This workforce decline jeopardizes patient outcomes, antibiotic stewardship, infection prevention, and public health responses to pandemics and emerging infections.
Background
Infectious diseases cause 5–15% of annual deaths in the U.S., with COVID-19 recently ranking as the third leading cause of mortality. ID physicians play a critical role beyond direct patient care, including antibiotic stewardship, infection prevention, and public health leadership. However, the ID workforce is contracting due to low compensation, immigration barriers, political antagonism, and high administrative burdens. This decline threatens healthcare quality and public health infrastructure amid growing infectious disease challenges.
Data Highlights
Metric
Value
Number of ID physicians in U.S.
~14,000 (<1% of physician workforce)
Counties with no or few ID doctors
~90% (80% none, 10% few)
ID physicians with active licenses
2008: 6,424; 2018: 9,136; 2025: 9,774
Unfilled ID training programs
~50%
Average EHR time per 8 hours patient care
8.4 hours
COVID-19 mortality (2020-2022)
1 in 10 Americans
Key Findings
ID physicians improve outcomes by reducing hospital stay length, costs, and managing complex infections.
80% of U.S. counties lack ID specialists, limiting local expertise for infection management.
ID specialists contribute critically to public health agencies like CDC and WHO for outbreak response and antimicrobial stewardship.
Low compensation and high administrative burden discourage recruitment and retention in ID specialty.
Immigration policy hurdles restrict international medical graduates from filling ID workforce gaps.
Political hostility and harassment against public health workers exacerbate workforce attrition.
Clinical Implications
The shrinking ID workforce endangers effective infection management, antibiotic stewardship, and pandemic preparedness. Healthcare systems must recognize the value of ID specialists and implement strategies to improve compensation, reduce administrative burdens, and support workforce diversity. Policymakers should address immigration and political challenges to sustain this critical specialty.
Conclusion
The decline of infectious disease specialists poses a significant threat to patient safety and public health infrastructure in the U.S. Urgent action is needed to reverse this trend and preserve the specialty’s vital role in combating infectious threats.
References
CDC and WHO Reports on Infectious Diseases and Public Health, 2023
Health Resources & Services Administration Data, 2025
Recent Studies on ID Workforce and Compensation, 2024
Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.
